---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/43500227.md"
description: "$KUAISHOU-W(01024.HK)$HENGRUI PHARMA(01276.HK)Kuaishou's performance is quite poor, but the management of this company has little credibility to begin with. For me, this after-hours meeting doesn't add any new negative points.I currently hold about a 2% position and have no intention of adding to it at the moment.My Hengrui position is slightly larger than Kuaishou's, but I haven't had time to look into it closely yet.However, looking at the stock price, even with such a strong run in the pharmaceutical sector, it still managed to drop. This suggests there are likely some significant underlying issues 🙃"
datetime: "2026-08-20T01:49:17.000Z"
locales:
  - [en](https://longbridge.com/en/topics/43500227.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/43500227.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/43500227.md)
author: "[大花卷](https://longbridge.com/en/profiles/12196320.md)"
generator: "portal-rs"
---

# $KUAISHOU-W(01024.HK)$HENGRUI PHARMA(01276.HK)Kuai…


### Related Stocks

- [600276.CN](https://longbridge.com/en/quote/600276.CN.md)
- [01024.HK](https://longbridge.com/en/quote/01024.HK.md)
- [01276.HK](https://longbridge.com/en/quote/01276.HK.md)
- [81024.HK](https://longbridge.com/en/quote/81024.HK.md)
- [HKUD.SG](https://longbridge.com/en/quote/HKUD.SG.md)

## Comments (8)

- **lyhalfway · 2026-08-20T02:22:35.000Z · 👍 1**: Kuaishou's Hong Kong IPO price was actually over 400, and it has dropped so sharply...
  - **akski** (2026-08-20T02:30:28.000Z): 👻👻👻 There are too many ghost stories in the Hong Kong stock market; a $400 stock price is no different from bankruptcy.
  - **大花卷** (2026-08-20T03:31:21.000Z): At that time, Kuaishou was firmly in the top 2 for both short videos and live-stream e-commerce... If it can still achieve a top 2 spot now, the valuation might be well over 400 😂
  - **大花卷** (2026-08-20T03:32:00.000Z): Of course, I don't think there's any chance of going back.
- **自我搏击 · 2026-08-20T01:59:59.000Z**: This earnings report is terrible, and the conference call failed to provide investors with a satisfactory answer, effectively signaling: "We still have significant room for further decline."}
- **不回本我不走（ing · 2026-08-20T01:54:39.000Z**: I bought A-share pharma and precisely hit a landmine with Hengrui 🤕, positioning it amidst the flowers
  - **大花卷** (2026-08-20T01:57:02.000Z): Mainly didn't get the spillover benefits from the healthcare sector rally, which is a bit frustrating, but shouldn't lose too much 😇
  - **不回本我不走（ing** (2026-08-20T01:58:30.000Z): Lucky I bought in at 52.5; I trimmed my Hong Kong innovative drug ETF positions to buy this, and got crushed. From now on, I'll stick to ETFs for these kinds of plays.


---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**